New oral drugs show promise for the treatment of multiple sclerosis

被引：0
|
作者：
不详
机构：
来源：
FUTURE MEDICINAL CHEMISTRY | 2010年 / 2卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：308 / 308
页数：1
相关论文
共 50 条
  • [41] Guidelines for the treatment of multiple sclerosis with immunomodulatory drugs
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (3B) : 892 - 895
  • [42] Circulating miRNA markers show promise as new prognosticators for multiple myeloma
    A Rocci
    C C Hofmeister
    S Geyer
    A Stiff
    M Gambella
    L Cascione
    J Guan
    D M Benson
    Y A Efebera
    T Talabere
    V Dirisala
    E M Smith
    P Omedè
    G Isaia
    L De Luca
    D Rossi
    S Gentili
    G Uccello
    J Consiglio
    R Ria
    G Benevolo
    S Bringhen
    V Callea
    B Weiss
    A Ferro
    V Magarotto
    H Alder
    J C Byrd
    M Boccadoro
    G Marcucci
    A Palumbo
    F Pichiorri
    Leukemia, 2014, 28 : 1922 - 1926
  • [43] Circulating miRNA markers show promise as new prognosticators for multiple myeloma
    Rocci, A.
    Hofmeister, C. C.
    Geyer, S.
    Stiff, A.
    Gambella, M.
    Cascione, L.
    Guan, J.
    Benson, D. M.
    Efebera, Y. A.
    Talabere, T.
    Dirisala, V.
    Smith, E. M.
    Omede, P.
    Isaia, G.
    De Luca, L.
    Rossi, D.
    Gentili, S.
    Uccello, G.
    Consiglio, J.
    Ria, R.
    Benevolo, G.
    Bringhen, S.
    Callea, V.
    Weiss, B.
    Ferro, A.
    Magarotto, V.
    Alder, H.
    Byrd, J. C.
    Boccadoro, M.
    Marcucci, G.
    Palumbo, A.
    Pichiorri, F.
    LEUKEMIA, 2014, 28 (09) : 1922 - 1926
  • [44] Two new drugs in the treatment of Multiple Sclerosis: BG-12 and Alemtuzumab
    Kurtuncu, Murat
    TURKISH JOURNAL OF NEUROLOGY, 2013, 19 (01) : 36 - 37
  • [45] Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study
    Ruggieri, S.
    Prosperini, L.
    Al-Araji, S.
    Annovazzi, P.
    Bisecco, A.
    Ciccarelli, O.
    De Stefano, N.
    Filippi, M.
    Fleischer, V.
    Evangelou, N.
    Enzinger, C.
    Gallo, A.
    Garjani, A.
    Groppa, S.
    Haggiag, S.
    Khalil, M.
    Lucchini, M.
    Mirabella, M.
    Montalban, X.
    Pozzilli, C.
    Preziosa, P.
    Rio, J.
    Rocca, M. A.
    Rovira, A.
    Stromillo, M. L.
    Zaffaroni, M.
    Tortorella, C.
    Gasperini, C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 657 - 659
  • [46] Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study
    Ruggieri, S.
    Prosperini, L.
    Al-Araji, S.
    Bisecco, A.
    Ciccarelli, O.
    de Stefano, N.
    Filippi, M.
    Fleischer, V.
    Evangelou, N.
    Gallo, A.
    Garjan, A.
    Groppa, S.
    Haggiag, S.
    Lucchini, M.
    Mirabella, M.
    Montalban, X.
    Pozzilli, C.
    Preziosa, P.
    Rio, J.
    Rocca, M. A.
    Rovira, A.
    Stromillo, M. L.
    Tortorella, C.
    Gasperini, C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 658 - 659
  • [47] A milestone in multiple sclerosis treatment: what changed in the landscape of the multiple sclerosis treatment with oral medications
    Ozakbas, S.
    Cinar, B. Piri
    Yorgun, Y. Guven
    Kahraman, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 925 - 925
  • [48] New drugs and personalized medicine for multiple sclerosis
    Matthews, Paul M.
    NATURE REVIEWS NEUROLOGY, 2015, 11 (11) : 614 - 616
  • [49] Multiple Sclerosis: Prospects and Promise
    Hauser, Stephen L.
    Chan, Jonah R.
    Oksenberg, Jorge R.
    ANNALS OF NEUROLOGY, 2013, 74 (03) : 317 - 327
  • [50] New drugs and personalized medicine for multiple sclerosis
    Paul M. Matthews
    Nature Reviews Neurology, 2015, 11 : 614 - 616
12345